These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23104523)

  • 1. Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD.
    Torgersen T; Gjervan B; Rasmussen K; Vaaler A; Nordahl HM
    Atten Defic Hyperact Disord; 2013 Mar; 5(1):59-67. PubMed ID: 23104523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for more than 3 years' duration of central stimulant treatment in adult attention-deficit/hyperactivity disorder: a retrospective, naturalistic study.
    Torgersen T; Gjervan B; Nordahl HM; Rasmussen K
    J Clin Psychopharmacol; 2012 Oct; 32(5):645-52. PubMed ID: 22926598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
    van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
    Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility.
    Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K
    Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with a positive occupational outcome during long-term central stimulant treatment in adult ADHD.
    Torgersen T; Krokstad S; Vaaler AE
    Atten Defic Hyperact Disord; 2014 Dec; 6(4):281-90. PubMed ID: 24700330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Substance use disorders and ADHD: an overview of recent Dutch research].
    van Emmerik-van Oortmerssen K; Crunelle CL; Carpentier PJ
    Tijdschr Psychiatr; 2013; 55(11):861-6. PubMed ID: 24242145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.
    Faraone SV; Biederman J; Wilens TE; Adamson J
    Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
    Simon N; Rolland B; Karila L
    Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC; Bisgaard C
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit/hyperactivity disorder and early-onset substance use disorders.
    Wilson JJ; Levin FR
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):751-63. PubMed ID: 16262592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
    Schubiner H
    CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders.
    Skoglund C; Brandt L; D'Onofrio B; Larsson H; Franck J
    Eur Neuropsychopharmacol; 2017 Nov; 27(11):1144-1152. PubMed ID: 28935267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability.
    Sizoo B; van den Brink W; Koeter M; Gorissen van Eenige M; van Wijngaarden-Cremers P; van der Gaag RJ
    Drug Alcohol Depend; 2010 Feb; 107(1):44-50. PubMed ID: 19786328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
    Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
    Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-age clinical and developmental features associated to Substance Use Disorders in Attention-Deficit/Hyperactivity Disorder in Adults.
    Nogueira M; Bosch R; Valero S; Gómez-Barros N; Palomar G; Richarte V; Corrales M; Nasillo V; Vidal R; Casas M; Ramos-Quiroga JA
    Compr Psychiatry; 2014 Apr; 55(3):639-49. PubMed ID: 24411652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
    Brynte C; Aeschlimann M; Barta C; Begeman AHA; Bäcker A; Crunelle CL; Daigre C; De Fuentes-Merillas L; Demetrovics Z; Dom G; López LG; Icick R; Johnson B; Joostens P; Kapitány-Fövény M; Karsinti E; Kiefer F; Konstenius M; Levin FR; Luderer M; Markus W; Matthys F; Moggi F; Palma-Alvarez RF; Paraskevopoulou M; Ramos-Quiroga JA; Schellekens A; Soravia LM; Therribout N; Thomas A; van de Glind G; van Kernebeek MW; Vollstädt-Klein S; Vorspan F; van den Brink W; Franck J
    BMC Psychiatry; 2022 Sep; 22(1):625. PubMed ID: 36151539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.